In Brief: FDA FY 1998 operations
This article was originally published in The Gray Sheet
FDA FY 1998 operations: Agency's budget plan detailing its $925 mil. fiscal 1998 budget allocation, signed into law Nov. 18 as part of the agriculture appropriations bill, is under revision by the Office of Management and Budget and HHS. Originally due to the Appropriations Committee Dec. 18, a draft proposal is understood to have been submitted on time but returned to FDA for further work...
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.